Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
59 Cards in this Set
- Front
- Back
3 types of formularies
|
Open Formulary
|
|
open formulary
|
a formulary with few
|
|
closed formulary
|
a formulary that restricts access to non-formulary drugs.
|
|
Partially open or incentive-based formulary
|
a formulary that allows access to non-formulary drugs
|
|
Decisions about what drugs should be on a formulary often are made by
|
a pharmacy and therapeutics (P & T) committee (role of this committee varies across orgs)
|
|
P&T committee composed of...(4)
|
composed of physicians
|
|
patient cost sharing requirements
|
Under most prescription drug insurance plans
|
|
3 purposes of cost sharing
|
To directly reduce insurer costs by shifting costs to patients.
|
|
3types of pt cost sharing
|
deductible
|
|
deductible
|
the amount (e.g. $500) that patients have to pay toward their medical expenses before the insurance coverage begins
|
|
3 properties of deductibles
|
Typically covers some period of time (e.g. one year).
|
|
coinsurance vs copayment
|
Coinsurance: patients pay a set percentage of the cost of prescriptions (e.g. 20 percent).
|
|
multi tier copayments- two vs three tier copays
|
Two-tier copayment: two levels of copayments.
|
|
e.g. $10 for generic drugs
|
$20 for brand name drugs
|
|
e.g. $10 for generic drugs
|
$20 for preferred brand name drugs and $45 for non-preferred drugs.
|
|
now
|
how many tiers are commonly seen for copays
|
|
specialty drugs
|
biotech drugs and drugs for some serious diseases (e.g. cancer
|
|
give example
|
specialty drugs
|
|
Recent example is Provenge to treat advanced prostate cancer with a $93
|
000 price per course of treatment. (cost per month often thousands of dollars)
|
|
PBMs - how are they managing specialty drugs? (3)
|
tighter management of specialty drugs
|
|
how PBMs have dealt with specialty drugs (3)
|
tighter mgmt
|
|
2010 health care reform and biologic drugs (biotech)
|
The 2010 health care reform law included a pathway for approval of generic biologics
|
|
value based benefit design
|
Copayments and other cost-sharing amounts are based on the value of the drug
|
|
Incentives for Generic Substitution (4)
|
pt financial incentives: Differential copayments
|
|
Other Benefit Restrictions (2)
|
Days supply or other quantity limitation.
|
|
Many prescription drug plans limit the quantity dispensed
|
often to a 30 days supply though may be longer for chronic meds (90 days)
|
|
cap on # of rx per month was instigated by/used by whom
|
medicaid
|
|
prior auth
|
a process or protocol whereby the third party payer limits coverage of selected medication to patients meeting predetermined specifications
|
|
who can initiate PA process
|
Depending on the plan
|
|
prior auth involves the insurer
|
how?
|
|
used for what?
|
Programs that review
|
|
Can occur before
|
during or after dispensing.
|
|
what is DSM? (disease state management)
|
comprehensive
|
|
DSM programs usually target (2)
|
chronic
|
|
DSM programs focus on what for the pt (4)
|
education
|
|
case management vs. disease state management (main difference)
|
many of the same components as DSM programs
|
|
Patients typically are selected for case management based on what? (2)
|
high utilization and/or high expenditures
|
|
which state program has a pharmaceutical case mgmt program?
|
Iowa Medicaid has a pharmaceutical case management program
|
|
Clinical Practice Guidelines
|
Systematically developed statements that assist practitioners in the proper management of a given disease.
|
|
Step Protocols
|
Access to an expensive drug is based on failing less expensive therapy.
|
|
3 other tools for controlling drug costs
|
clinical practice guidelines
|
|
PBM-Pharmacy Contract Battles- example
|
walgreens and express scripts
|
|
big blow to walgreens
|
Rationale was low reimbursement under Express Scripts.
|
|
what gives PBMs the right to audit pharmacies
|
Under pharmacy contracts with PBMs
|
|
desk audits
|
“Desk audits” where the pharmacy must submit information on selected prescriptions to the PBMs
|
|
on-site audits
|
where a PBM auditor comes to the pharmacy to check records.
|
|
common outcome of audits
|
Audits often result in pharmacies having to pay back money to the PBMs
|
|
evidence of quality of PBM audits changing
|
Anecdotal evidence that both the frequency and intensity of PBM audits are increasing
|
|
describe what a restrictive network is
|
a pharmacy chain or other small group of pharmacies that have agreed to accept lower reimbursement rates.
|
|
how patients are coerced into using restrictive networks (2)
|
Patients may be required to use the network pharmacies (e.g. required to mail order)
|
|
trends in restrictive pharmacy networks and PBMs
|
Seeing a trend toward some very restrictive pharmacy networks being offered as an option to PBM customers.
|
|
mail order pharmacies: how are they coercing pt to do this (2)
|
Either mandatory or incentives to use.
|
|
Mail order is often chosen by employers who are hoping to do what
|
to reduce prescription drug costs
|
|
laws regarding mail order pharmacies. why?
|
NY law that bans mail order incentives (see reading).
|
|
do mail order pharmacies save money?
|
Controversy over how much mail order pharmacies save.
|
|
pharmacy direct contracting- give example of what this is (and store)
|
Wal-Mart has a program where companies can direct contract with Wal-mart for prescriptions filled by their employees at Wal-mart.
|
|
explain how walmart direct contracting works (how does company pay wal-mart
|
incentives to use)
|
|
testing of walmart direct contract program
|
Caterpillar pilot tested this program. (wtf)
|
|
What are advantages and disadvantages of this model for pharmacies? (pharmacy direct contract program)
|
--
|